期刊文献+

低分子肝素治疗胎儿生长受限的效果及对围生儿结局的影响 被引量:3

Effect of low molecular weight heparin in the treatment of fetal growth restriction and its influence on perinatal outcome
下载PDF
导出
摘要 目的探索低分子肝素治疗胎儿生长受限的效果及对围生儿结局的影响。方法选择120例胎儿生长受限的孕妇为试验对象,根据单双号随机化法将其分为对照组和观察组,各60例。对照组采用常规治疗,观察组采用低分子肝素治疗。比较两组的收缩期血液流速高值/舒张晚期血液流速高值(S/D)、阻力指数(RI)、搏动指数(PI)、胎儿每周生长发育情况(双顶径、腹围、头围、宫高)、胎儿的生物物理评分、治疗效果及围生儿结局。结果治疗后,观察组S/D、RI、PI均低于对照组(P<0.05)。观察组每周双顶径、腹围、头围、宫高增长情况均优于对照组(P<0.05)。治疗后,观察组胎儿的生物物理评分高于对照组(P<0.05)。观察组的治疗总有效率高于对照组(P<0.05)。观察组极低体重儿、早产儿、新生儿窒息、胎儿窘迫发生率均低于对照组(P<0.05)。结论运用低分子肝素治疗胎儿生长受限的效果显著,有利于改善围生儿结局,促使胎儿健康生长、发育。 Objective To explore the effect of low molecular weight heparin in the treatment of fetal growth restriction and its influence on perinatal outcome.Methods A total of 120 pregnant women with fetal growth restriction were selected as the test objects.The pregnant women were randomly divided into control group and observation group by single and double numbers randomized method,with 60 cases in each group.The control group was given conventional treatment,and the observation group was treated with low molecular weight heparin.The high blood flow rate during systole/high blood flow rate during late diastole(S/D),resistance index(RI),pulsatility index(PI),fetal weekly growth and development(double top diameter,abdominal circumference,head circumference,uterine height),fetal biophysical score,treatment effect and perinatal outcome were compared between the two groups.Results After treatment,S/D,RI and PI in the observation group were lower than those in the control group(P<0.05).The weekly growth of double top diameter,abdominal circumference,head circumference and uterine height in the observation group were better than those in the control group(P<0.05).After treatment,the fetal biophysical score in the observation group was higher than that in the control group(P<0.05).The total effective rate of treatment in the observation group was higher than that in the control group(P<0.05).The incidences of very low birth weight infants,premature infants,neonatal asphyxia and fetal distress in the observation group were lower than those in the control group(P<0.05).Conclusion The low molecular weight heparin in the treatment of fetal growth restriction has a significant effect,which can improve the perinatal outcome and promote the healthy growth and development of fetus.
作者 乔艳妮 王春娟 QIAO Yanni;WANG Chunjuan(Obstetrics Department,Weinan Maternal and Child Health Hospital,Weinan 714000,China)
出处 《临床医学研究与实践》 2021年第1期124-126,共3页 Clinical Research and Practice
关键词 低分子肝素 胎儿生长受限 围生儿结局 血液参数 low molecular weight heparin fetal growth restriction perinatal outcome blood parameters
  • 相关文献

参考文献7

二级参考文献60

  • 1苏华.低分子肝素钙治疗胎儿宫内生长受限疗效分析[J].临床研究,2014,22(6):67-67. 被引量:1
  • 2段涛,张振钧.妊高征孕妇血管内皮细胞形态及功能变化的研究[J].中华妇产科杂志,1994,29(11):642-644. 被引量:14
  • 3于昕,林延峰.低分子量肝素对妊高征大鼠肾脏病变的保护作用及机制初步探讨[J].中国应用生理学杂志,2005,21(2):212-215. 被引量:13
  • 4谢幸,苟文丽.妇产科学[M].第8版.北京:人民卫生出版社,2013:258-264.
  • 5Baschat AA. Fetal growth restriction-from observation to intervention[M]. J Perinat Med, 2010,38(3) :239-246.
  • 6Hatem A, Mousa, Pam Loughna. Fetal growth restriction : Investigation and treatment[J]. Obstetrics Gynecology and Reproductive Medicine, 2008,18 (9) : 247-252.
  • 7黎淑琳.低分子肝素在胎儿生长受限治疗中的疗效分析[J].中外健康文摘,2013,10(24):229.
  • 8Missfelder-Lobos H, Teran E, Lees C, et al. Plateletchanges and subsequent development of pre-eclampsiaand fetal growth restriction in women with abnormal uterineartery Doppler screening [J]. Ultrasound ObstetGynecol, 2002, 19(5): 443-8.
  • 9Riyazi N, Leeda M, de Vries JI, et al. Low-molecularweightheprin combined with aspirin in pregnant womenwith thrombophilia and a history of pre -eclampsia orfetal growth restriction: a preliminary study [J]. Eur JObstet Gynecol Reprod Biol, 1998, 80(1): 49-54.
  • 10Chan P, Brown M, Simpson JM, et a l Proteinuria in preeclampsia:how much matters)[J]. BJOG, 2005, 112(3): 280-5.

共引文献112

同被引文献27

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部